Noninvasive test for the diagnosis of ovarian hormone-secreting-neoplasm in postmenopausal women.

about

Noninvasive test for the diagnosis of ovarian hormone-secreting-neoplasm in postmenopausal women.

Item

http://www.wikidata.org/entity/Q36569645

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Noninvasive test for the diagn ...... plasm in postmenopausal women.

@ast

Noninvasive test for the diagn ...... plasm in postmenopausal women.

@en

type

Item

label

Noninvasive test for the diagn ...... plasm in postmenopausal women.

@ast

Noninvasive test for the diagn ...... plasm in postmenopausal women.

@en

prefLabel

Noninvasive test for the diagn ...... plasm in postmenopausal women.

@ast

Noninvasive test for the diagn ...... plasm in postmenopausal women.

@en

P1476

Noninvasive test for the diagn ...... plasm in postmenopausal women.

@en

P2093

Ami Fishman

http://www.w3.org/2001/XMLSchema#string

Dan Nabriski

http://www.w3.org/2001/XMLSchema#string

Ilan Cohen

http://www.w3.org/2001/XMLSchema#string

P2860

Ovarian hyperandrogenism and androgen-producing tumors.

Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome.

Testosterone secretion by cultured arrhenoblastoma cells: suppression by a luteinizing hormone-releasing hormone agonist.

Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist.

Impact of clinical, hormonal, radiological, and immunohistochemical studies on the diagnosis of postmenopausal hyperandrogenism.

Granulosa cell tumours of the ovary.

Diagnosis and localization of testosterone-producing ovarian tumors: imaging or biochemical evaluation.

Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?

Gonadotropin-releasing hormone agonist analog therapy effective in ovarian granulosa cell malignancy.

Short term administration of gonadotropin-releasing hormone analog to a patient with a testosterone-secreting ovarian tumor.

P304

12-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.GORE.2015.06.002

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

278049675

http://www.w3.org/2001/XMLSchema#string

P698

26937480

http://www.w3.org/2001/XMLSchema#string

P932

4750012

http://www.w3.org/2001/XMLSchema#string